Landscapes / Companies
Evergreen Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 5 in all
Trials
4 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Mar 2027Phase 2 trial completes | |||
| Next date | Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Endometrial Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | Jun 2028Phase 2 trial completes | |||
| Next date | Jun 2028 · Phase 2 trial completes | ||||
| Also tested for | Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2027Phase 1 trial completes | |||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Pre-eclampsia | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021